Immunome (IMNM)
(Delayed Data from NSDQ)
$15.55 USD
+1.39 (9.82%)
Updated Jun 5, 2024 04:00 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Brokerage Reports
Immunome, Inc. [IMNM]
Reports for Purchase
Showing records 1 - 15 ( 15 total )
Company: Immunome, Inc.
Industry: Medical - Biomedical and Genetics
Company: Immunome, Inc.
Industry: Medical - Biomedical and Genetics
Company: Immunome, Inc.
Industry: Medical - Biomedical and Genetics
Company: Immunome, Inc.
Industry: Medical - Biomedical and Genetics
Company: Immunome, Inc.
Industry: Medical - Biomedical and Genetics
Company: Immunome, Inc.
Industry: Medical - Biomedical and Genetics
Company: Immunome, Inc.
Industry: Medical - Biomedical and Genetics
Company: Immunome, Inc.
Industry: Medical - Biomedical and Genetics
Company: Immunome, Inc.
Industry: Medical - Biomedical and Genetics
Company: Immunome, Inc.
Industry: Medical - Biomedical and Genetics
Company: Immunome, Inc.
Industry: Medical - Biomedical and Genetics
Company: Immunome, Inc.
Industry: Medical - Biomedical and Genetics
Company: Immunome, Inc.
Industry: Medical - Biomedical and Genetics
Initiating Coverage at OUTPERFORM: A Metamorphosis for Immunome
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Immunome, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for IMNM 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Immunome, Inc.
Industry: Medical - Biomedical and Genetics
|